Siegfried Holding AG
SGFEF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.86B
Close$
$47.79
45.8% downside
Current Fair Value
45.8% downsideOvervalued by 45.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.86 Billion |
|---|---|
| Enterprise Value | $4.68 Billion |
| Annual dividend | $0.51 |
| Dividend yield | 0.55% |
| Earnings per Share | $3.85 |
| Beta | 0.81 |
| Outstanding Shares | 43,923,870 |
Return
| Return on Equity | 32.72% |
|---|---|
| Return on Assets | 13.46% |
| Return on Invested Capital | 19.67% |
Valuation & Multiples
| P/E Ratio | 18.71 |
|---|---|
| PEG | 455.49 |
| Price to Sales | 1.47 |
| Price to Book Ratio | 4.01 |
| Enterprise Value to Revenue | 1.78 |
| Enterprise Value to EBIT | 11.53 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.93 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
$1.97
Consensus analyst estimateRevenue Estimate
$767.97 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 19, 2027
EPS Estimate
$3.03
Consensus analyst estimateRevenue Estimate
$954.37 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Siegfried Holding AG
3,891 employees
CEO: Marcel Imwinkelried
Siegfried Holding AG is a global participant in the life sciences industry. The company's core activities involve crafting and producing active pharmaceutical ingredients (APIs), intermediate compounds, and a diverse portfolio of finishe...